retatrutide phase 2 trial weight loss results VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide Phase 2 Results: 24.2%

While clinical data is limited, peptide therapy may have a place in hormone regulation

Role of hypothalamic proopiomelanocortin neuron autophagy in the control of appetite and leptin response

Oral semaglutide may also cause specific side effects related to its daily dosing schedule, such as more frequent gastrointestinal discomfort

255 Restoring the NAD + levels via de novo biosynthesis in the liver prevents hepatic lipid accumulation and attenuates inflammation in mice on a high-fat diet (HFD)

For example, prostate cancer and B-cell lymphomas promote FAO as the main source of energy production and express FAO enzymes at high levels, even under nutrient-replete conditions 10,11